S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
Latest› Regulation› Story
Regulation · July 6, 2026

Alphatur Sues Canaras, U.S. Bank Over $50M CLO Collateral Loss, Alleging Concealment

A Miami investor claims the managers and trustee hid the deterioration of collateral in three CLO funds, leading to a total loss of its investment.

Alphatur Sues Canaras, U.S. Bank Over $50M CLO Collateral Loss, Alleging Concealment Photo · James O'Connell for InvestLin

A Miami-based investor has taken legal action against the managers and trustee of three collateralized loan obligation funds, alleging they concealed the complete loss of a $50 million investment. The case, filed July 4 in Manhattan federal court, underscores the critical importance of collateral management and recordkeeping in structured finance.

Alphatur Inc. claims it placed $50 million into the Saranac CLO III, V, and VII programs. CLOs are structured vehicles that issue securities backed by pools of corporate loans, making the quality and oversight of the underlying collateral paramount. The complaint names Canaras Capital Management, Saranac CLO Management, and U.S. Bank Trust Company as defendants.

According to the filing, Canaras pitched itself in July 2013 as a New York-based SEC-registered investment adviser specializing in corporate CLO management. Alphatur alleges it was assured that the collateral backing its notes would be preserved, monitored, and released only in accordance with governing documents. Instead, the complaint asserts that the defendants "authorized, permitted, recorded, concealed, or failed to prevent" collateral releases and transfers that "materially impaired the collateral base and destroyed Plaintiff's investment."

The complaint further alleges that the defendants downplayed the severity of the situation, describing "catastrophic deterioration and collateral impairment as ordinary volatility." This characterization is central to the securities fraud claims brought under Section 10(b) and Rule 10b-5, along with control-person liability and New York state claims for breach of contract, breach of fiduciary duty, and gross negligence. Limited relief is also sought under the Investment Advisers Act.

By the numbers
$50M
Alphatur's investment lost
3
CLO funds involved (Saranac III, V, VII)
July 4
Date lawsuit filed in Manhattan federal court
Oct 2025
U.S. Bank letter denying record of Alphatur

U.S. Bank, as trustee and collateral administrator, faces a narrower set of allegations. Alphatur states it is not suing the bank as a guarantor or primary architect of the conduct, but rather for failing to keep accurate records, police collateral releases, and provide proper notice. The dispute over recordkeeping is particularly contentious. Alphatur says U.S. Bank responded in an October 2025 letter confirming its role as successor trustee on the three CLOs, yet reported having no record of Alphatur holding any note under the indentures. Canaras's counsel, according to the complaint, argued that Alphatur never cleared Jersey know-your-customer checks and that some activity reports were "prepared in 2025 and backdated to 2023 as an accommodation."

For financial advisors and compliance teams, this case serves as a stark reminder of the long-term implications of how losses are communicated to clients, how ownership and collateral records are maintained, and how trustees document their responsibilities. The integrity of fund plumbing—collateral, records, and oversight—can determine the outcome of investments years after the deal closes.

Alphatur is seeking more than $50 million in damages, a full accounting, and declaratory and injunctive relief, and has demanded a jury trial. The case highlights ongoing scrutiny of CLO structures and the fiduciary duties of managers and trustees, echoing themes in recent SEC enforcement probes into private equity continuation vehicles and the importance of transparent reporting.

As the litigation unfolds, advisors may want to review how they evaluate CLO investments and the due diligence conducted on trustees and collateral administrators. The case also reinforces the need for clear communication with clients about the risks inherent in structured products, especially when market conditions shift. For a broader perspective on investor protections, see coverage of foreign investors suing a Miami developer over an EB-5 visa scheme, which similarly hinges on alleged misrepresentations.

JO
About the author

James O'Connell

Regulation & Compliance Editor · Washington, D.C.

Covers the SEC, FINRA, DOL and state regulators from Washington, D.C.

Next story · Don't miss

Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors

Bankruptcy court approves sale of 30 properties, but investor recoveries remain uncertain amid fee disputes and arbitration hurdles.

Read the story →
Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors